Answers are grounded in this paper and cite their sources.
The utility of DNA analysis and proliferating cell nuclear antigen (PCNA) for estimating prognosis of advanced pancreatic cancer was examined with formalin-fixed and paraffin-embedded sections of tumors from 24 patients with pancreatic cancer (stage IV). The histopathological findings, stage and curability had no relationship to DNA ploidy pattern, S-phase fraction and PCNA score. Single variant analysis revealed the followings: 1) There were significant differences in cumulative survival rates between stage IVa and stage IVb, and between curability B and curability C. 2) The DNA ploidy pattern was not a significant prognostic factor, but all of the 3 patients who survived more than 800 days had diploid tumors. 3) The PCNA score was not a significant prognostic factor, but all of the 5 patients who survived more than 500 days had tumors with less than 25%. Cox's multivariate analysis revealed that the PCNA score was the most important prognostic factor (p<0.05). These results suggest that the PCNA score reflects proliferative activity and is useful as a prognostic index of advanced pancreatic cancer (stage IV).
No takes yet. Share an insight, caveat, or question.
Nomura et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: